Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.69 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.67 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.67 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 4/20 | 0.57 |
| ▸ | TERT | O14746 | 3/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | PPARD | Q03181 | 3/20 | 0.57 |
| ▸ | PPARA | Q07869 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | BLM | P54132 | 2/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.57 |
| ▸ | FABP4 | P15090 | 2/20 | 0.57 |
| ▸ | F7 | P08709 | 2/20 | 0.57 |
| ▸ | F3 | P13726 | 2/20 | 0.57 |
| ▸ | GMNN | O75496 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2510598 | 1.00 | FASN (0.69) | FASNGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL9444672 | 1.00 | FASN (0.69) | FASNGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL5414634 | 0.98 | FASN (0.67) | FASNGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL5414638 | 0.98 | FASN (0.67) | FASNGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL9845712 | 0.94 | FASN (0.62) | FASNGPR84FFAR1FFAR4KDM4E | |
| SCHEMBL23925418 | 0.91 | FFAR1 (0.73) | GPR84FFAR1FFAR4KDM4EPPARG | |
| SCHEMBL23225824 | 0.91 | FFAR1 (0.73) | GPR84FFAR1FFAR4KDM4EPPARG | |
| SCHEMBL7161160 | 0.91 | FFAR1 (0.73) | GPR84FFAR1FFAR4KDM4EPPARG | |
| SCHEMBL23950035 | 0.91 | FFAR1 (0.73) | GPR84FFAR1FFAR4KDM4EPPARG | |
| SCHEMBL22634134 | 0.91 | FFAR1 (0.73) | GPR84FFAR1FFAR4KDM4EPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3419616-A1 | METHODS OF TREATING LACTOSE INTOLERANCE | Nogra Pharma Limited (IE) | 2019-01-02 | — | — | EP | disclosed |
| WO-2017144725-A1 | METHODS OF TREATING LACTOSE INTOLERANCE | NOGRA PHARMA LIMITED (IE) | 2017-08-31 | — | — | WO | disclosed |
| US-20100022646-A1 | METHOD OF NEUTRALISING ORGANOBORONATES WITH ACIDS | TRIGEN LIMITED (GB) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022646-A1 | METHOD OF NEUTRALISING ORGANOBORONATES WITH ACIDS | LIPC, CYP8B1, SCD | FASN 49/4885GPR84 872/4885FFAR1 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.